Mujun Zhao
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Broad-spectrum antitumor analysis of the telomerase activity inhibitor TPCH derived from the human constitutively expressed protein LPTS/PinX1.
Journal: Frontiers in oncology
Published: June 08, 2025
Preparation and anticancer activity of telomerase inhibitor TAT-LPTS39 polypeptide.
Journal: Translational cancer research
Published: May 13, 2024
A scalable and reproducible preparation for the antitumor protein TLC, a human-derived telomerase inhibitor.
Journal: Protein expression and purification
Published: March 30, 2021
Hepatic loss of Lissencephaly 1 (Lis1) induces fatty liver and accelerates liver tumorigenesis in mice.
Journal: The Journal of biological chemistry
Published: December 14, 2017
Dysfunction of PLA2G6 and CYP2C44-associated network signals imminent carcinogenesis from chronic inflammation to hepatocellular carcinoma.
Journal: Journal of molecular cell biology
Published: December 17, 2016
Lis1 is required for the expansion of hematopoietic stem cells in the fetal liver.
Journal: Cell research
Published: May 24, 2014
Adenovirus-mediated delivery of siRNA targeting TM4SF4 attenuated liver cancer cell growth in vitro and in vivo.
Journal: Acta biochimica et biophysica Sinica
Published: January 09, 2013
Human tetraspanin transmembrane 4 superfamily member 4 or intestinal and liver tetraspan membrane protein is overexpressed in hepatocellular carcinoma and accelerates tumor cell growth.
Journal: Acta biochimica et biophysica Sinica
Published: January 13, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026